Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-22-000094

Chief R&D Officer returned 657 shares (to the company)

  • Chief R&D Officer acquired 2,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scopelianos Angelo · Chief R&D Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-18 Grant or award : show line 1 in the form +2,571 22,751 D
2022-07-19 Returned to the company : show line 2 in the form −657 $8.40 $5,519 25,094 D
Loading xslF345X03/wf-form4_165834747880252.xml…